Inventor

DUAN JINGWU

US52 patents

⚠️ This page may combine multiple inventors who share the name “DUAN JINGWU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DUAN JINGWU

BRISTOL MYERS SQUIBB CO

Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- α converting enzyme (TACE)

Tricyclic sulfones as RORγ modulators

Tricyclic sulfones as RORγ modulators

Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases

Cyclic compounds useful as modulators of TNF α

Pyrrolidinyl sulfone RORγ modulators

Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases

Lactam metalloprotease inhibitors

Heterocyclic compounds useful as modulators of TNF alpha

Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity, and use thereof

ROR γ modulators

Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)

Tricyclic sulfones as RORγ modulators

Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

Bicyclic lactam derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)

Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases

Carbocyclic sulfone RORγ modulators

Heterocyclic sulfone RORγ modulators

Cyclic sulfone derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)

RORγ modulators

RORγ modulators

Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

Hydantoin derivatives as inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)

Tricyclic heterocyclic compounds useful as inhibitors of TNF

Cyclohexyl sulfone RORγ modulators

BRISTOL MYERS SQUIBB PHARMA CO

Lactam metalloprotease inhibitors

Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)

Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)

β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α

Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanase

Lactam inhibitors of matrix metalloproteinases, TNF-α and aggrecanase

Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α

Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α

Matrix metalloproteinase inhibitors

Cyclic sulfonamide derivatives as metalloproteinase inhibitors

Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)

Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE)

DUAN JINGWU

Azaindazoles as kinase inhibitors and use thereof

Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

Fused heteroaryl modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

DU PONT PHARM CO

Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanase

Macrocyclic compounds as metalloprotease inhibitors

WROBLESKI STEPHEN T

Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases

Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases

DU PONT

Lactam metalloprotease inhibitors

DE LUCCA GEORGE V

Nicotinamide compounds useful as kinase modulators

BRISTOL MYERS SQUIBB PHARME CO

Lactam metalloprotease inhibitors

BRISTOL MYERS SQUIBB PHARMA

Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE)